| Literature DB >> 8400349 |
J B Matthews1, H Adomat, K A Skov.
Abstract
The literature contains conflicting evidence regarding the hypoxic toxicity of cisplatin. We have found that in Chinese hamster ovary cells, cisplatin was up to 2.6 times more effective at reducing survival to 2% in hypoxic, compared with aerobic cells. Furthermore, using atomic absorption spectroscopy, it was determined that cells treated in hypoxia showed consistently higher accumulation (up to 1.5 times) and DNA binding (up to 1.7 times) than aerobic cells. Hypoxic cells also showed greater toxicity per platinum-DNA adduct than those treated in air, suggesting that increased binding of the drug, alone, cannot account for its increased hypoxic cytotoxicity. We suggest that the hypoxia selectivity of cisplatin involves several different mechanisms and possible explanations for these results are discussed.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8400349 DOI: 10.1097/00001813-199308000-00007
Source DB: PubMed Journal: Anticancer Drugs ISSN: 0959-4973 Impact factor: 2.248